Table 3. KI-67 protein expression in pretreatment and post-treatment biopsies in non-pCR stage 2 OTSCC.
Agea | Sex | Pretreatment biopsy (%) | Post-treatment biopsyb (%) | Δ change | Recurrence | Survival |
---|---|---|---|---|---|---|
58 | F | 58 | 27 | 31 | None | Alive |
33 | M | 81 | 18 | 63 | Locoregional | Dead |
38 | F | 53 | 24 | 29 | None | Alive |
54 | F | 50 | 41 | 9 | Locoregional | Dead |
53 | M | 43 | 31 | 12 | Locoregional | Dead |
32 | F | 68 | 60 | 8 | None | Alive |
58 | M | 49 | 35 | 14 | Locoregional | Alive |
61 | M | 55 | 54 | 1 | Locoregional | Dead |
21 | M | 58 | 47 | 11 | Locoregional | Dead |
57 | M | 66 | 28 | 38 | None | Alive |
75 | F | 72 | 53 | 19 | None | Alive |
P-value | P=0.001 | |||||
Mean | 59 | 38 | 21 | NA | NA | |
s.d. | 11.3 | 13.9 | 17.8 |
Patients received preoperative radiation (50–68 Gy).
Non-pCR (incomplete pathological remission).